# Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome

> **NCT00705172** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 41 (actual)

## Conditions studied

- Genetic Disorder
- Prader-Willi Syndrome

## Interventions

- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT00705172
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2023-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00705172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00705172, "Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome". Retrieved via MORVS 2026-10-15 from https://api.morvs.ai/clinical/NCT00705172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*